Research highlights need for gender-specific diagnosis of heart failure in type 2 diabetes patients

FHS
August 5, 2024
11:22 am

A MedUni Vienna study has investigated gender-specific differences in the diagnosis of systolic heart failure in patients with type 2 diabetes.

Mayo Clinic Platform Unveils Solutions Studio to Propel Digital Health Innovation

What You Should Know: – Mayo Clinic Platform launches Solutions Studio, a groundbreaking program designed to accelerate the development, validation, and deployment of digital health

March 16, 2024

Systasy Bioscience Announces Collaboration Agreement with Ono Pharmaceutical – Biotech Investments

EQS-News: Systasy Bioscience GmbH / Key word(s): Agreement Systasy Bioscience Announces Collaboration Agreement with Ono Pharmaceutical 31.07.2024 / 09:00 CET/CEST The issuer is solely responsible

August 1, 2024

FDA approves Skyline Therapeutics’ IND for macular degeneration trial – Pharmaceutical Technology

nAMD, which leads to severe visual impairment, is estimated to affect over 200 million people worldwide. Image credit: Shutterstock/air009. Chinese gene therapy company Skyline will

July 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.